• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Thoratec Corp.

Plaintiff’s lawyers seek legal fees in $12m Thoratec settlement

May 30, 2019 By Fink Densford

Attorneys representing investor Bradley Cooper are seeking approximately $3 million from Abbott (NYSE:ABT) owned Thoratec in legal fees and $392,445 in expenses for a lawsuit that the company settled in February for $11.9 million. In the original case, plaintiffs claimed that Thoratec and some of its officers hid facts about its Heartmate II heart pump’s thrombosis rate […]

Filed Under: Cardiovascular, Legal News Tagged With: Thoratec Corp.

Medtronic touts stroke data for HeartWare LVAD

April 5, 2019 By Brad Perriello

A retrospective analysis of two studies involved the HeartWare left-ventricular assist device Medtronic (NYSE:MDT) acquired in 2016 showed that managing blood pressure reduced the severity of strokes in patients implanted with the HVAD pump. The analysis, of “destination therapy” patients who are not candidates for a heart transplant, took data from the Endurance and Endurance […]

Filed Under: Clinical Trials, Featured, Structural Heart Tagged With: Abbott, HeartWare International Inc., Medtronic, stjudemedical, Thoratec Corp.

Thoratec inks $12m investor suit settlement deal

February 6, 2019 By Fink Densford

Abbott (NYSE:ABT) owned Thoratec is seeking approval for a $11.9 million deal to settle class action claims that it and some of its officers hid facts about its Heartmate II heart pump’s thrombosis rate that would have negatively affected share prices, according to recently released court documents. Investor Bradley Cooper originally brought the suit against the company […]

Filed Under: Business/Financial News, Cardiovascular, Legal News, Structural Heart Tagged With: Abbott, Thoratec Corp.

Investors win class certification in lawsuit against Abbott’s Thoratec

May 10, 2018 By Fink Densford

A group of Thoratec shareholders this week won a class certification in a revived suit claiming that Thoratec, now owned by Abbott (NYSE:ABT), and some of its officers hid facts about its HeartMate II heart pump’s rate of thrombosis that would have negatively affected share prices, thereby misleading investors. Investor Bradley Cooper originally brought the suit against the company […]

Filed Under: Cardiac Implants, Cardiovascular, Legal News Tagged With: Abbott, Thoratec Corp.

Appeals court revives Thoratec shareholders suit

October 6, 2017 By Sarah Faulkner

A Ninth Circuit panel this week revived a shareholders suit against Thoratec (NSDQ:THOR), deciding that it was a mistake for a lower court to dismiss the case and that investors had sufficient grounds for claiming that the company misled them. The securities class action suit was brought against Thoratec in January 2014. Investor Bradley Cooper sued the […]

Filed Under: Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Legal News, Wall Street Beat Tagged With: Thoratec Corp.

Deaths prompt Abbott recall of Thoratec HeartMate II controllers

May 24, 2017 By Brad Perriello

Abbott (NYSE:ABT) is recalling nearly 29,000 controllers for the HeartMate II implantable heart pump made by its Thoratec subsidiary after 26 patients died trying to change out the controllers on their own. The March 29 recall of 28,882 controllers for the HeartMate II left ventricular assist device follows 70 reports of “incidents in which the […]

Filed Under: Recalls, Structural Heart, Wall Street Beat Tagged With: Abbott, Thoratec Corp.

St. Jude Medical’s HeartMate 3 implantable pump beats HeartMate II in pivotal trial

November 16, 2016 By Brad Perriello

The next-generation HeartMate 3 implantable pump St. Jude Medical (NYSE:STJ) acquired when it paid $3 billion for Thoratec last year proved superior to the older HeartMate II device at 6 months in pivotal clinical trial results released today. The Momentum 3 study enrolled more than 1,000 patients for a short-term outcome after 6 months and a longer-term, […]

Filed Under: Cardiovascular, Clinical Trials, Structural Heart Tagged With: American Heart Assn., New England Journal of Medicine, stjudemedical, Thoratec Corp.

St. Jude posts street-beating Q1

April 20, 2016 By Fink Densford

Updated with guidance information for Q2 and full year 2016. St. Jude Medical (NYSE:STJ) released 1st quarter 2016 results that beat the Street, despite seeing profits slip from the same quarter last year after its acquisition of Thoratec. St. Paul, Minn.-based St. Jude Medical reported profits of $95 million, or 33¢ per share, on sales of […]

Filed Under: Business/Financial News Tagged With: stjudemedical, Thoratec Corp.

Autonomic Technologies taps ex-Thoratec’s Pellegrini for CEO | Personnel Moves April 15, 2016

April 15, 2016 By Fink Densford

Autonomic Technologies taps ex-Thoratec’s Pellegrini for CEO Autonomic Technologies said it hired ex-Thoratec North America prez Niamh Pellegrini as its new CEO and member of its board. Read more

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10

Filed Under: Business/Financial News Tagged With: Anika Therapeutics Inc., Autonomic Technologies, Cardiovascular Systems Inc., COTA, DJO Global, Expanding Orthopedics, Haemonetics, Hologic, integer, Personnel Moves, Thoratec Corp.

Thoratec sales exceed forecast for St. Jude Medical

January 13, 2016 By Brad Perriello

Share prices for St. Jude Medical (NYSE:STJ) slid today after the medical device company missed forecasts for its 4th-quarter sales, despite a higher-than-expected contribution from its newly acquired Thoratec implantable heart pump business, and raised the low end of its earnings outlook. Little Canada, Minn.-based St. Jude said it expects to post sales of $1.45 billion for the 3 months […]

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: stjudemedical, Thoratec Corp.

St. Jude Medical wins CE Mark for HeartMate 3 pump

October 12, 2015 By Brad Perriello

St. Jude Medical (NYSE:STJ) said today that its newly acquired HeartMate 3 implantable heart pump won CE Mark approval in the European Union, less than a week after the medical device company closed its $3 billion acquisition of Thoratec. HeartMate 3, a left ventricular assist device, is designed for heart failure patients who are awaiting a […]

Filed Under: Regulatory/Compliance, Structural Heart Tagged With: stjudemedical, Thoratec Corp.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 12
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS